疫苗前沿 | 3-17岁人群接种两剂克尔来福疫苗是安全的，且能够诱导较强的抗体反应

2021

07/01

预防界.

A-

A+

《柳叶刀-感染病学》（The Lancet Infectious Diseases）6月28日发表的一项针对550名儿童及青少年的随机对照试验显示，3-17岁人群接种两剂克尔来福（CoronaVac）疫苗是安全的，且能够诱导较强的抗体反应。研究结果显示，接种两剂疫苗后96%以上的人群产生了中和抗体反应；且研究中观察到的不良反应多数为轻度和中度，注射部位疼痛是最常见的症状。

NOTES TO EDITORS

This study was funded by the National Key Research and Development Program and the Beijing Science and Technology Program. It was conducted by researchers from Hebei Provincial Center for Disease Control and

Prevention, Sinovac Biotech Ltd, National Institutes for Food and Drug Control, Zanhuang County Center for Disease Control and Prevention, Beijing Key Tech Statistics Technology Co., Ltd., and Sinovac Life Sciences Co, Ltd, China.

[1] https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30987-7/fulltext; https://www.thelancet.com/article/S1473-3099(20)30843-4/fulltext

[2] Quote direct from author and cannot be found in the text of the Article.

*中文翻译仅供参考，所有内容以新闻稿原文为准。

来源：柳叶刀TheLancet